01

Sigma-Aldrich Corporation

U.S.A

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Levodopa

CAS Number : 59-92-7

Quantity Per Vial :

Sale Unit :

Price : $125.00

Details :

Monograph : PHR1271-500MG

Storage : +2°C to +8°C

Portfolio PDF

Corporate PDF

02

Sigma-Aldrich Corporation

U.S.A

CPhI WW Frankfurt

Booth #9.1D64

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Levodopa Related Compound A

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $691.00

Details :

Monograph : PHR2095-100MG

Storage : +2°C to +8°C

Portfolio PDF

Corporate PDF

03

Sigma-Aldrich Corporation

U.S.A

CPhI WW Frankfurt

Booth #9.1D64

Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

Levodopa Related Compound B

CAS Number :

Quantity Per Vial :

Sale Unit :

Price : $691.00

Details :

Monograph : PHR2096-100MG

Storage : +2°C to +8°C

Portfolio PDF

Corporate PDF

04

ALK

Denmark

Aus. Peptide Conference

Not Confirmed

05

Aozeal Certified Standards

U.S.A

Aus. Peptide Conference

Not Confirmed

06

Cyclo Therapeutics

U.S.A

Aus. Peptide Conference

Not Confirmed

07

OneHealthPort

U.S.A

Aus. Peptide Conference

Not Confirmed

08

Piramal Pharma Solutions

U.S.A

Aus. Peptide Conference

Not Confirmed

Etilevodopa

Etilevodopa

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

47 API Suppliers

20 USDMF

14 CEP/COS

4 JDMF

2 EU WC

9 KDMF

11 NDC API

16 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

66 Drugs in Development

INTERMEDIATES

4 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

734 FDF Dossiers

134 FDA Orange Book

513 Europe

33 Canada

14 South Africa

40 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG

TABLET;ORAL - 25MG;100MG

TABLET;ORAL - 25MG;250MG

TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG

CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG

CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG

CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG

TABLET;ORAL - 12.5MG;200MG;50MG

TABLET;ORAL - 18.75MG;200MG;75MG

TABLET;ORAL - 25MG;200MG;100MG

TABLET;ORAL - 31.25MG;200MG;125MG

TABLET;ORAL - 37.5MG;200MG;150MG

TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

4 Evonik

4 Rochem International Inc

21 SPI Pharma

8 DKSH

8 Boai NKY Pharmaceuticals Ltd

8 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

4 Kirsch Pharma

1 ACG Worldwide

8 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

29 BASF

1 CD Formulation

12 Corel Pharma Chem

6 DFE Pharma

1 Esteem Industries

1 Finar

12 Gangwal Chemicals

9 Ideal Cures

5 Ingredion Pharma Solutions

22 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

17 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons